Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1Diabetes Mellitus 1

Interventions

Metformin 3pembrolizumab 1Therapeutics 1Testosterone 1Pancreaticoduodenectomy 1Magnetic Resonance Spectroscopy 1Hypoglycemic Agents 1Gonadotropin-Releasing Hormone 1Glucose Tolerance Test 1Gastric Bypass 1Folic Acid 1Exergaming 1Endodontics 1Dexamethasone 1DNA 1Continuous Glucose Monitoring 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Diabetes Mellitus × Glucose Tolerance Test × Clear all
NCT03415139 2022-03-28

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

Vanderbilt-Ingram Cancer Center

Unknown
120 enrolled

Diabetes Mellitus, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡